Skip to main content
Year archive

Alkem Laboratories Limited — 2021 filings

All 156 regulatory filings released by Alkem Laboratories Limited (ALKEM) in 2021, sourced directly from the official regulator.

156 Filings
2021 Period
2021 filings (156)
Filing Released Lang
Reply to Clarification Sought
Regulatory Filings
2021-12-24 English
Trading Window
Regulatory Filings
2021-12-21 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th December, ....
Regulatory Filings
2021-12-21 English
Updates
Regulatory Filings
2021-12-20 English
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management ....
Regulatory Filings
2021-12-20 English
Change in Director(s)
Board/Management Information
2021-12-20 English
We wish to inform you that the Board of Directors ('Board') of Alkem Laboratories Limited (the 'Company'), at its meeting held today, i.e. on 20th December, 2021 has appointed Mrs. Madhurima ....
Regulatory Filings
2021-12-20 English
Disclosure under SEBI (PIT) Reg 2015
Regulatory Filings
2021-12-02 English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated ....
Regulatory Filings
2021-11-30 English
Related Party Transactions
Regulatory Filings
2021-11-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-11-15 English
We enclose herewith the transcript of the 'Q2 FY2022 Earnings Conference Call' which was hosted by the Company on Friday, 12th November, 2021. The said transcript shall also ....
Regulatory Filings
2021-11-15 English
We refer to our earlier communication dated 27th September, 2021 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th September, 2021) starting ....
Regulatory Filings
2021-11-12 English
Trading Window
Regulatory Filings
2021-11-12 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q2FY22 and ....
Regulatory Filings
2021-11-12 English
Investor Presentation
Regulatory Filings
2021-11-12 English
In continuation of our letter dated 02nd November, 2021 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2021-11-12 English
Financial Result Updates
Regulatory Filings
2021-11-12 English
The Board of Directors at its meeting held today i.e. 12th November, 2021, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th ....
Regulatory Filings
2021-11-12 English
Outcome of Board Meeting
Regulatory Filings
2021-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-11-03 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2FY22 and ....
Regulatory Filings
2021-11-03 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2021-11-02 English
Board Meeting — Financial Results
Regulatory Filings
2021-11-02 English
Demise
Regulatory Filings
2021-10-28 English
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we regret to inform you of the sad demise of Mr. Dhananjay Kumar Singh, Joint Managing ....
Regulatory Filings
2021-10-28 English
Trading Window
Regulatory Filings
2021-09-27 English
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th September, ....
Regulatory Filings
2021-09-27 English
This is to inform you that the Board of Directors of the Company vide Circular Resolution passed on 16th September, 2021 approved the closure of operations at Beta Block (Unit II) manufacturing ....
Regulatory Filings
2021-09-20 English
Updates
Regulatory Filings
2021-09-20 English
Shareholders meeting
Regulatory Filings
2021-08-27 English
This is with reference to the 47th Annual General Meeting (''AGM'') of the Company held on Friday, 27th August, 2021 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). ...
Regulatory Filings
2021-08-27 English
This is with reference to the 47th Annual General Meeting ('AGM') of the Company held on Friday, 27th August, 2021 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). ....
Regulatory Filings
2021-08-27 English
We refer to our earlier communication dated 25th June, 2021 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th June, 2021) starting from ....
Regulatory Filings
2021-08-06 English
Trading Window
Regulatory Filings
2021-08-06 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY22 earnings ....
Regulatory Filings
2021-08-06 English
Investor Presentation
Investor Presentation
2021-08-06 English
In continuation of our letter dated 26th July, 2021 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2021-08-06 English
Financial Result Updates
Regulatory Filings
2021-08-06 English
Outcome of Board Meeting
Regulatory Filings
2021-08-06 English
The Board of Directors at its meeting held today i.e. 06th August, 2021, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021. ....
Regulatory Filings
2021-08-06 English
Press Release
Regulatory Filings
2021-08-04 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') has launched Ibuprofen and Famotidine Tablets in the United States, following an approval from the ....
Regulatory Filings
2021-08-04 English
This is to inform you that US FDA had conducted a remote and virtual Bio-Analytical inspection of the Company's Bioequivalence Center located at Taloja, Maharashtra from 26th July, ....
Regulatory Filings
2021-07-29 English
Press Release
Regulatory Filings
2021-07-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-07-28 English
With reference to our earlier intimation dated 27th July, 2021 informing that a conference call shall be held on Friday, 06th August, 2021 at 04.30 pm to discuss the Q1FY22 financial results, ....
Regulatory Filings
2021-07-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-07-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-07-27 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q1FY22 financial ....
Regulatory Filings
2021-07-27 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2021-07-26 English
Board Meeting — Financial Results
Regulatory Filings
2021-07-26 English
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"}, please find enclosed herewith ....
Regulatory Filings
2021-07-17 English
Copy of Newspaper Publication
Report Publication Announcement
2021-07-17 English
Please find enclosed herewith the Notice of the 47th Annual General Meeting of the Company scheduled to be held on Friday, 27th August, 2021 at 11.00 a.m. through Video Conferencing (VC)/ ....
Regulatory Filings
2021-07-16 English
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-07-08 English
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-07-08 English
Copy of Newspaper Publication
AGM Information
2021-07-07 English
Pursuant to Regulation 30 and 47 read along with Schedule III of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith ....
Regulatory Filings
2021-07-07 English
Trading Window
Regulatory Filings
2021-06-25 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th June, 2021 ....
Regulatory Filings
2021-06-25 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-06-22 English
Alkem Laboratories Ltd has submitted to BSE a copy of Disclosures under Regulations 4(1) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Regulatory Filings
2021-06-22 English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Kumar Singh & Aniruddha Singh
Regulatory Filings
2021-06-22 English
Disclosure under SEBI (PIT) Reg 2015
Regulatory Filings
2021-06-22 English
In terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report for the period ....
Regulatory Filings
2021-06-21 English
Press Release
Regulatory Filings
2021-06-19 English
This is to inform you that US FDA had conducted an inspection of the Company's manufacturing facility located at St. Louis, USA from 14th June, 2021 to 18th June, 2021. At the ....
Regulatory Filings
2021-06-19 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2021-06-11 English
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-06-11 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') has launched Perampanel Tablets in India under the brand name 'Perampil', an affordable anti-epileptic drug for the ....
Regulatory Filings
2021-06-10 English
Press Release (Revised)
Regulatory Filings
2021-06-10 English
Press Release
Regulatory Filings
2021-06-10 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') has launched Perampanel Tablets in India under the brand name 'Perampil', an affordable anti-epileptic drug for the ....
Regulatory Filings
2021-06-10 English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated ....
Regulatory Filings
2021-06-09 English
Related Party Transactions
Regulatory Filings
2021-06-09 English
This is with reference to our earlier intimation letter dated today for outcome of the Board Meeting and intimation of record date, kindly note that the record date for the purpose of 47th ....
Regulatory Filings
2021-05-25 English
Updates
Regulatory Filings
2021-05-25 English
Restructuring
Regulatory Filings
2021-05-25 English
This is to inform you that the Company at its meeting held today i.e. 25th May, 2021, has approved the restructuring of the Company's Subsidiaries in USA. The disclosure pursuant ....
Regulatory Filings
2021-05-25 English
Change in Director(s)
Regulatory Filings
2021-05-25 English
The Board of Directors at its meeting held today i.e. 25th May, 2021, has, inter alia based on recommendation of Nomination and Remuneration Committee and subject to approval of shareholders ....
Regulatory Filings
2021-05-25 English
Trading Window
Regulatory Filings
2021-05-25 English
We refer to our earlier communication dated 26th March, 2021 regarding closure of trading window (for the purpose of financial results for the quarter and year ended 31st March, 2021) starting ....
Regulatory Filings
2021-05-25 English
Investor Presentation
Regulatory Filings
2021-05-25 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY21 and ....
Regulatory Filings
2021-05-25 English
The Board of Directors at its meeting held today i.e. 25th May, 2021, has, inter alia fixed 20th August, 2021 as the record date for the purpose of the Annual General Meeting and 10th ....
Regulatory Filings
2021-05-25 English
Record Date
Regulatory Filings
2021-05-25 English
Record Date
Annual Report
2021-05-25 English
The Board of Directors at its meeting held today i.e. 25th May, 2021, has, inter alia: 1. recommended a final dividend of Rs. 5/- (Rupees Five only) per equity share of Rs. 2/- ....
Regulatory Filings
2021-05-25 English
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2021, inter alia, has recommended a final dividend of Rs. 5/- (Rupees Five ....
Regulatory Filings
2021-05-25 English
continuation of our letter dated 14th May, 2021 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR (''Listing Regulations'') the Board of Directors of the Company, at ....
Regulatory Filings
2021-05-25 English
Financial Result Updates
Regulatory Filings
2021-05-25 English
Dividend
Annual Report
2021-05-25 English
The BOD at its meeting held today i.e. 25.05.21 has, inter alia approved the Standalone and Consolidated Audited Financial Statements for the quarter and FY ended 31.3.21 and other items ....
Regulatory Filings
2021-05-25 English
Outcome of Board Meeting
Annual Report
2021-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-05-18 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY21 and ....
Regulatory Filings
2021-05-18 English
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 25, 2021, inter alia:1. To consider and approve the ....
Regulatory Filings
2021-05-14 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2021-05-14 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve (i) to consider and approve ....
Regulatory Filings
2021-05-14 English
In furtherance to our intimation to the stock exchanges on 30th March 2021, that Alkem Laboratories Limited has subscribed to partnership interest to the extent of 12.5%in ABCD Technologies ....
Regulatory Filings
2021-04-30 English
Updates
Major Shareholding Notification
2021-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2021-04-29 English
Annual Disclosure
Regulatory Filings
2021-04-29 English
With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2021-04-12 English
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary ....
Regulatory Filings
2021-04-12 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-09 English
Updates
Regulatory Filings
2021-04-09 English
This is to inform you that the Board of Directors of the Company approved the commencement of commercial production/ operations at the Chakan manufacturing facility of Enzene Biosciences ....
Regulatory Filings
2021-04-09 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-07 English
We refer to our disclosure, dated 01st April, 2021, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 informing interalia that DigiHealth ....
Regulatory Filings
2021-04-06 English
Updates
M&A Activity
2021-04-06 English
Updates
M&A Activity
2021-04-01 English
We would like to inform you that DigiHealth Technologies LLP, the wholly owned entity of our Indian investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), ....
Regulatory Filings
2021-04-01 English
Updates
Capital/Financing Update
2021-03-31 English
We would like to inform you that our investee company i.e. ABCD Technologies LLP (to be renamed as IndoHealth Technologies LLP) has through its wholly-owned entity DigiHealth Services LLP, ....
Regulatory Filings
2021-03-31 English
This is to inform you that Alkem Laboratories Limited has agreed in principle to subscribe to a partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth services LLP). ....
Regulatory Filings
2021-03-30 English
Acquisition
Regulatory Filings
2021-03-30 English
Trading Window
Regulatory Filings
2021-03-26 English
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th March, ....
Regulatory Filings
2021-03-26 English
Amendment to AOA/MOA
Regulatory Filings
2021-03-25 English
This is to inform you that shareholders of the Company, through Postal Ballot process, have approved the special resolution for the amendments to Memorandum of Association (MOA) of the ....
Regulatory Filings
2021-03-25 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2021-03-25 English
In continuation of our letter dated 22nd February, 2021 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this ....
Regulatory Filings
2021-03-25 English
Press Release
Regulatory Filings
2021-03-23 English
This is to intimate you that Alkem Laboratories Limited has agreed to partner with Tata Memorial Centre to establish an advanced Radiotherapy Facility as a part of the Homi Bhabha Cancer ....
Regulatory Filings
2021-03-23 English
Press Release
Regulatory Filings
2021-03-15 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') has launched Brivaracetam in India under the brand name 'Brivasure', an affordable anti-epileptic drug for the treatment ....
Regulatory Filings
2021-03-15 English
Pursuant to Regulation 30 and 47 read alongwith Schedule Ill of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"}, please find enclosed herewith ....
Regulatory Filings
2021-02-23 English
Copy of Newspaper Publication
Regulatory Filings
2021-02-23 English
In furtherance to our intimation dated 05.02.2021, this is to inform you that pursuant to the provisions of Sec 110 and other applicable provisions, if any, of the Companies Act, 2013 read ....
Regulatory Filings
2021-02-22 English
Shareholders meeting
Proxy Solicitation & Information Statement
2021-02-22 English
Trading Window
Regulatory Filings
2021-02-05 English
Investor Presentation
Regulatory Filings
2021-02-05 English
We refer to our earlier communication dated 28th December, 2020 regarding closure of trading window (for the purpose of financial results for the quarter ended 31st December, 2020) starting ....
Regulatory Filings
2021-02-05 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q3FY21 and ....
Regulatory Filings
2021-02-05 English
Updates
Regulatory Filings
2021-02-05 English
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management ....
Regulatory Filings
2021-02-05 English
Record Date
Regulatory Filings
2021-02-05 English
In continuation of our letter dated 27th January, 2021 the Board of Directors of the Company, at its meeting held today, i.e. 05th February, 2021 inter alia, has declared Interim Dividend ....
Regulatory Filings
2021-02-05 English
Amendment to AOA/MOA
Regulatory Filings
2021-02-05 English
We wish to inform you that the Board of Directors ('Board') of the Company, at its meeting held today, i.e. 05th February, 2021 have inter alia approved alteration to Memorandum of Association ....
Regulatory Filings
2021-02-05 English
Financial Result Updates
Regulatory Filings
2021-02-05 English
In continuation of our letter dated 27th January, 2021 and pursuant to Regulation 30 read with Regulation 33 and Regulation 42 of the Securities and Exchange Board of India (Listing Obligations ....
Regulatory Filings
2021-02-05 English
In continuation of our letter dated 27th January, 2021 and pursuant to Regulation 30 read with Regulation 33 and Regulation 42 of the Securities and Exchange Board of India (Listing Obligations ....
Regulatory Filings
2021-02-05 English
Dividend
Regulatory Filings
2021-02-05 English
Outcome of Board Meeting
Interim / Quarterly Report
2021-02-05 English
Pursuant to Reg 30 read with Reg 33 and Reg 42 of the SEBI (LODR) Regulations, 2015 , the Board of Directors of the Company, at its meeting held today, i.e. 05th February, 2021 have inter alia: ....
Regulatory Filings
2021-02-05 English
Press Release
Call Transcript
2021-01-29 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY21 and ....
Regulatory Filings
2021-01-29 English
Record Date
Notice of Dividend Amount
2021-01-27 English
The record date for the purpose of payment of Interim Dividend for the Financial Year 2020-2021, would be Saturday, 13th February, 2021, subject to declaration of the said Interim Dividend ....
Regulatory Filings
2021-01-27 English
The record date for the purpose of payment of Interim Dividend for the Financial Year 2020-2021, would be Saturday, 13th February, 2021, subject to declaration of the said Interim Dividend ....
Regulatory Filings
2021-01-27 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021 ,inter alia, to consider and approve (i) the Standalone and Consolidated ...
Regulatory Filings
2021-01-27 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2021-01-27 English